𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol

✍ Scribed by Farideh Beigi; Carlo Bertucci; Weizhong Zhu; Khalid Chakir; Irving W. Wainer; Rui-Ping Xiao; Darrell R. Abernethy


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
283 KB
Volume
18
Category
Article
ISSN
0899-0042

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Separation of (3S, 3′S)-, (3R 3′R)- and
✍ Vecchi, Max ;Müller, Robert K. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract A method is described for the qualitative and quantitative determination of configurational isomers of astaxanthin. It is based on the esterification of astaxanthin with (—)‐camphanic acid chloride and analysis of the corresponding diesters by HPLC.

An improved process of separation of R-
✍ Erika Várkonyi-Schlovicskó; Kálmán Takács; István Hermecz 📂 Article 📅 1997 🏛 Journal of Heterocyclic Chemistry 🌐 English ⚖ 169 KB 👁 1 views

## Abstract Diastereomeric timolol tartrates 4 are obtained in a one‐pot synthesis from the racemic base 2 and optically active __O,O__‐diacetyl‐ or __O,O__‐dibenzoyltartaric anhydrides 3, as only one of the diastereomers precipitates from acetone solution. Acidic hydrolysis as the corresponding 4

Separation of (3R, 3′R)-, (3R, 3′S;meso)
✍ Rüttimann, A. ;Schiedt, K. ;Vecchi, M. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

A method is described for the qualitative and quantitative determination of configurational isomers of zeaxanthin (= 3,3' -dihydroxy-P, p -carotene) and lutein (= 3 3 -dihydroxya-carotene). It is based on the reaction of these zeaxanthin and lutein isomers with (S)-(+)-e-(l -naphthyl) ethyl isocyana

Syntheses and β-adrenergic binding affin
✍ Adeboye Adejare; Stacey A. Deal; Michael S. Day Jr. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

The beta-adrenergic receptors mediate several physiological processes including heart rate (beta 1), bronchodilation (beta 2), and lipolysis (beta 3). Therefore, selectivity is important for a possible therapeutic agent acting via these receptors. Aryloxypropanolamines are beta-receptor agonists or